Figure 3 illustrates the imaging characteristics of PET/MRI (A and C) and IVIM (B and D) in a high-risk and low-risk prostate cancer patient with Ki-67 expression levels of 30% and 2%, respectively. This evidence concerns the gene MKI67 and prostate carcinoma.